Literature DB >> 28513866

LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.

Xiaoming Wang1,2, Xiubo Lu1,2, Zushi Geng1,2, Guoyu Yang1,2, Yang Shi1,2.   

Abstract

The distance metastases of papillary thyroid carcinoma (PTC) were a major threaten for PTC patients, thus, to study the potential mechanism for the treatment of PTC was essential. Previous studies have shown that PTCSC3 (Thyroid Carcinoma Susceptibility Candidate 3), miR-574-5p and Wnt/β-catenin were involved in PTC, but the potential pathogenic mechanism among them was still unclear. Real-time PCR and Western blot were used to detect genes expression. Luciferase reporter assay was used to detect the combination of miR-574-5p and suppressor of cancer cell invasion (SCAI), as well as the ratio of TOP/FOP. RNA Pull-down assay verified the bound of PTCSC3 and miR-574-5p. MTT assay, Transwell assay, and wound scratch assay were used to detect cell viability and cell migration. The expression of PTCSC3 and SCAI were decreased, while miR-574-5p and β-catenin were increased in PTC tissues and cells. Overexpressed PTCSC3 suppressed cell proliferation and migration, promoted the expression of SCAI, but inhibited β-catenin. PTCSC3 absorbed miR-574-5p, and miR-574-5p targeted to SCAI; SCAI could regulate the activity of Wnt/β-catenin. PTCSC3/miR-574-5p regulated the activity of Wnt/β-catenin via SCAI and mediated cell proliferation and migration of PTC-1. In vivo experiments verified the fact that overexpressed PTCSC3 inhibited tumor growth. The signaling PTCSC3-miR-574-5p-SCAI-Wnt/β-catenin mediated the proliferation and migration of PTC-1 cells, which was vital for the further PTC therapy and prognosis. J. Cell. Biochem. 118: 4745-4752, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  MIGRATION; PROLIFERATION; PTC; PTCSC3; Wnt/β-CATENIN; miR-574-5p

Mesh:

Substances:

Year:  2017        PMID: 28513866     DOI: 10.1002/jcb.26142

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  40 in total

1.  Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway.

Authors:  Fukun Chen; Zhiping Feng; Jialun Zhu; Pengjie Liu; Chuanzhou Yang; Rongkai Huang; Zhiyong Deng
Journal:  Cancer Biol Ther       Date:  2018-09-12       Impact factor: 4.742

2.  LncRNA LINC00473 promoted colorectal cancer cell proliferation and invasion by targeting miR-195 expression.

Authors:  Shilei Li; Chunyu Lv; Jun Li; Tao Xie; Xianbin Liu; Zhiwei Zheng; Zhaoyang Qin; Xizeng Hui; Yang Yu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.

Authors:  Xiao-Ming Wang; Yang Liu; Yu-Xia Fan; Zheng Liu; Qing-Ling Yuan; Meng Jia; Zu-Shi Geng; Ling Gu; Xiu-Bo Lu
Journal:  Cancer Biol Ther       Date:  2018-05-03       Impact factor: 4.742

4.  LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p.

Authors:  Ling Yuan; Tingting Ma; Wenjing Liu; Yan Chen; Qihui Yuan; Mengyi Ye; Lei Yu; Jiaxin Li; Yang Niu; Yi Nan
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

5.  LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p.

Authors:  Min Zhang; Yinghui Song; Lijuan Yu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

6.  LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.

Authors:  Yongjie Xin; Xu He; Wei Zhao; Meixiao Zhan; Yong Li; Jing Xiao; Ke He; Ligong Lu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

7.  LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.

Authors:  Qingjun Yang; Jin Sun; Yifei Ma; Chunjie Zhao; Jijun Song
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

8.  A novel lncRNA-miRNA-mRNA network analysis identified the hub lncRNA RP11-159F24.1 in the pathogenesis of papillary thyroid cancer.

Authors:  Wei Jiang; Hua Zhan; Yanyan Jiao; Sha Li; Weixu Gao
Journal:  Cancer Med       Date:  2018-11-26       Impact factor: 4.452

Review 9.  Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.

Authors:  Qian Bai; Zhenjie Pan; Ghulam Nabi; Farooq Rashid; Yang Liu; Suliman Khan
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

10.  Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.

Authors:  Cunrong Chen; Lili Zhou; Hui Wang; Junnian Chen; Wen Li; Wei Liu; Mingjie Shen; Hongzhou Liu; Xiaomin Fu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.